by
Lisa Chamoff, Contributing Reporter | July 19, 2021
From the July 2021 issue of HealthCare Business News magazine
In the second half of 2020, the company released ProFound AI Risk for 2D mammography. It plans to release the solution for DBT next quarter.
The software looks at three features — age, breast density and subtle mammographic features, — to provide an “accurate two-year risk assessment that is truly personalized for each woman,” said Stacey Stevens, president of iCAD.
“Instead of recommending that every woman who turns 40 be screened with mammography we believe the future of screening will be based on individual risk,” Stevens said. “This technology is going to make mammography screening more personalized, and we are proud to be on the leading-edge of this exciting paradigm shift that will truly have a positive impact on patient care.”
Ikonopedia Tableau monitor 2
Ikonopedia
Ikonopedia recently launched a new product called Ikonopedia Insight, an interactive data visualization tool that provides insight into patient and clinical data already entered into the system, including patient information, imaging exams and follow-up, to generate a variety of BI-RADS-compliant static reports that give a high-level summary of key information.
“Taking the idea of making data work for customers now goes a step further,” said Emily Crane, Ikonopedia's chief executive officer.
Through interactive, colorful and frequently-updated visualizations, customers will be able to learn more about patient demographics and determine who may need more frequent screenings, identify organizational operational trends to decide where staffing adjustments may be needed to address patient volume load, identify personnel and potential training gaps and more.
“The solution uses Tableau reporting tools to create end-to-end reports,” Crane said. “For example, facilities can research breast screening based on patient demographics and risk.”
“Before, we could create reports for clients, but they couldn’t do it on their own,” Crane said. “Clients are making actionable changes to how they’re doing things based on the reports, including implementing improvements in high-risk follow-up, resolution of aging BI-RADS and even patient education across specific demographics.”
Additionally, in January, Ikonopedia added questions to its survey to help identify and track the impact COVID-19 has had on breast imaging and to help aid doctors in identifying patients who had recently had the COVID-19 vaccine, so they weren’t performing unnecessary biopsies.
